IL-23 and IL-17: function, disease and therapy
|
|
- Arron French
- 7 years ago
- Views:
Transcription
1 IL-23 and IL-17: function, disease and therapy Daniele Conte a.a. 2006/2007
2 IL-23/IL-17 axis in inflammation and infection Yoichiro Iwakura and Harumichi Ishigame, 2006, IL-23/IL-17 axis in inflammation, jci, 116
3 IL-23
4 Preferential action of IL-23 on Memory T Cells Frucht DM. IL-23: a cytokine that acts on memory T cells. Sci STKE 2002;2002:PE1. IL-23 promote cellular immune response
5 IL-23 in diseases: IL-23 in autoimmune inflammation IL-23 plays a central role in the establishment and maintenance of organ-specific inflammatory autoimmune diseases. IL-23p19 KO mice are resistant to EAE, CIA Cua, D.J., et al Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:
6 IL-23 in diseases: Pro-tumour activity of IL-23 Langowski, J. L. et al., IL-23 promotes tumour incidence and growth. Nature, : IL-17, G.CSF, granulocytes and macrophages are decreased in IL-23 KO IL-12 and IL-23 antagonize each other in tumour surveillance
7 IL 17
8 Function of Th17 cells David C. Wraith, Anti-cytokine vaccines and immunotherapy of autoimmune diseases, Eur. J. Immunol :
9 The IL-17 super family Pleiotropic activity of the IL 17-family Major function of IL-17A/F/E Major function is chemoattractant activity through the induction of cytokines and chemokines: IL-17A and IL-17F: neutrophili IL-17E : eosinophili IL-17A and IL-17F have role in airway hyper responsiveness and other pathological changes including metaplasia and airway remodeling Kawaguchi M et al., IL-17 cytokine family. J Allergy Clin Immunol 2004;114:
10 IL-17 synergize to other cytokines with IL-1 and TNF-α to drive expression of numerous infiammatory effector with IFN-γ to promote chemokine gene expression IL-17 is in the midst of a complex network that amplifies inflammation IL-17 play during adaptive or memory immune responses. IL-17 may be to trigger innate immune responses shortly after a second encounter with antigen, when the memory response is activated but when concentrations of antigen are still too low to trigger a full-scale innate immune response. Sarah L Gaffen, Biology of recently discovered cytokines: Interleukin-17 a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res Ther 2004, 6:
11 IL 17 in diseases: IL 17 in bone metabolism and arthritic process M I Koenders et al., Potential new target in arthritis therapy:interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis, Ann Rheum Dis 2006;65;29-33 Sarah L Gaffen, Biology of recently discovered cytokines: Interleukin-17 a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res Ther 2004, 6:
12 IL 17 in diseases: RA, CIA and EAE In RA IL-17 is upregulated in early disease IL-17 knockout mice are resistant to CIA Development of EAE is reduced in IL-17 knockout mice Lubberts, E., et al The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7: Komiyama, Y. Et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol :
13 IL 17 in diseases: IL-17 in other diseases Possible pathogenic role in viral infections (tropic Herpes virus saimiri) Elevated levels in bacterial infections Important role in immune response in the lung Patera AC, et al. : Interleukin 17 modulates the immune response to vaccinia virus infection. Virology 2002, 299: Linden A, Adachi M: Neutrophilic airway inflammation and IL- 17. Allergy 2002, 57: Sarah L Gaffen, Biology of recently discovered cytokines: Interleukin-17 a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res Ther 2004, 6:
14 IL 17 in diseases: in tumorigenesis The role played by IL-17 in tumorigenesis is complex
15 IL 17 in diseases: in tumorigenesis IL-17 promote growth and tumorigenicity of human cervical tumors in nude mice Tartour E, et al.: Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 1999, 59:
16 IL 17 in diseases: in tumorigenesis IL-17 inhibited the growth of hematopoietic tumors (mastocytoma P815 and lymphoma J558L in immunocompetent mice Benchetrit F, et al., Tartour E: Interleukin-17 inhibits tumor cell growth by means of a T-cell- dependent mechanism. Blood 2002, 99.
17 IL-17 in tumorigenesis: conclusion increased growth in nude mice IL-17 is pleiotropic a cytokine with opposite activities in the regulation of tumor growth Inhibition of immunogenic tumors in immunocompetent mice by T-cell-dependent mechanism Other cytokines have this feature These antagonistic activities of cytokines in the regulation of tumor growth, which often depends on the immunogenicity of the tumor model, must be taken into consideration when these molecules are used in trials of immunotherapy.
18 Immunotherapy of autoimmune diseases with Anti-cytokine vaccines
19 Autoimmune myocardits: IL17VLP vaccination IL-12 p35 KO and WT mice developed myocarditis p40 KO mice show low level of disease. Injection of anti-p19 antibody reduced the disease Sonderegger, I. et al., Neutralization of IL-17 by active vaccination inhibits IL-23-mediated autoimmune myocarditis. Eur. J. Immunol : DOI: /eji
20 Autoimmune arthritis: IL17-VLP vaccination CIA Rhn, T. A. et al., Vaccination against IL 17 suppresses autoimmune arthritis and encephalomyelitis Eur. J. Immunol : DOI: /eji
21 auto-immune encephalomyelitis IL17 chemically coupled to ovalbumin Uyttenhove, C. and Van Snick, J., Development of an anti-il 17A autovaccine that prevents experimental auto-immune encephalomyelitis Eur. J. Immunol : DOI: /eji
22 Conclusion Central role of IL-17 and 23 in certain organ specific inflammatory autoimmune diseases. Inhibition of IL-17 activity with anti-cytokine vaccines in mouse More extensive human studies to define the precise role of IL-17 IL-17 have displayed both pro- and anti-tumour activities. IL-12 and IL-23 antagonize each other in tumour surveillance. IL-17 was shown to enhance the cytotoxic T cell response to murine haematopoietic tumours It is difficult to predict the effect that IL-17 inhibition will have on the susceptibility of an individual to different types of cancer.
23 References Yoichiro Iwakura and Harumichi Ishigame, 2006, IL-23/IL-17 axis in inflammation, jci, 116 Frucht DM. IL-23: a cytokine that acts on memory T cells. Sci STKE 2002;2002:PE1. Lankford CS and Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003;73: Langowski, J. L. et al., IL-23 promotes tumour incidence and growth. Nature, : Chia-Hui Lo et al., Antitumor and antimetastatic activity of IL-23. J. Immunol. 171: Jing-Sheng Hao and Bao-En Shan, 2006, Immune enhancement and anti-tumor activity of IL-23, Cancer Immunol Immunother, 55: David C. Wraith, Anti-cytokine vaccines and immunotherapy of autoimmune diseases, Eur. J. Immunol : Sarah L Gaffen, Biology of recently discovered cytokines: Interleukin-17 a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res Ther 2004, 6: Kawaguchi M et al., IL-17 cytokine family. J Allergy Clin Immunol 2004;114: M I Koenders et al., Potential new target in arthritis therapy:interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis, Ann Rheum Dis 2006;65;29-3 Watford, W. T., et al Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202: Lankford, C. S. R. and Frucht, D. M., A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol : Sonderegger, I. et al., Neutralization of IL-17 by active vaccination inhibits IL-23-mediated autoimmune myocarditis. Eur. J. Immunol : DOI: /eji Rhn, T. A. et al., Vaccination against IL 17 suppresses autoimmune arthritis and encephalomyelitis Eur. J. Immunol : DOI: /eji Uyttenhove, C. and Van Snick, J., Development of an anti-il 17A autovaccine that prevents experimental auto-immune encephalomyelitis Eur. J. Immunol : DOI: /eji Numasaki, M. et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, (2003). Lubberts, E., M. I. Koenders, and W. B. van den Berg The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7:
24 Komiyama, Y. Et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol : Tartour E, et al.: Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 1999, 59: Benchetrit F, et al., Tartour E: Interleukin-17 inhibits tumor cell growth by means of a T-cell- dependent mechanism. Blood 2002, 99: Patera AC, et al. : Interleukin 17 modulates the immune response to vaccinia virus infection. Virology 2002, 299: Linden A, Adachi M: Neutrophilic airway inflammation and IL- 17. Allergy 2002, 57: Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, (2005). Cua, D.J., et al Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421: Murphy, C.A., et al Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:
25 IL-23 promoting cellular immunity its production in hematopoietic cells is critical. its biological activity requires cell-specific expression Its important in indirectly control of infections IL-23 modulates DC costimulatory function pathways of IL-12 and IL-23 are very similar IL-23could act to down-regulate Stat4-dependent actions of IL-12 unique role for IL-23 in promoting cellular immune responses Watford, W. T., et al Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202: Lankford, C. S. R. and Frucht, D. M., A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol :
26 IL-17 promotes angiogenesis and tumor growth Numasaki, M. et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, (2003).
27 IL-23 in diseases: IL-23 Promoting tumor incidence or anti-tumour activity? 27
28 Anti-tumour activity of IL-23 Chia-Hui Lo et al., Antitumor and antimetastatic activity of IL-23. J. Immunol. 171:
Chapter 43: The Immune System
Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2
More informationThe Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D.
The Most Common Autoimmune Disease: Rheumatoid Arthritis Bonita S. Libman, M.D. Disclosures Two googled comics The Normal Immune System Network of cells and proteins that work together Goal: protect against
More informationThe role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015
The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response
More informationANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1
AP BIOLOGY ANIMALS FORM & FUNCTION ACTIVITY #4 NAME DATE HOUR BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES Animals Form & Function Activity #4 page 1 INFLAMMATORY RESPONSE ANTIMICROBIAL
More informationAutoimmunity and immunemediated. FOCiS. Lecture outline
1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic
More information2) Macrophages function to engulf and present antigen to other immune cells.
Immunology The immune system has specificity and memory. It specifically recognizes different antigens and has memory for these same antigens the next time they are encountered. The Cellular Components
More informationName (print) Name (signature) Period. (Total 30 points)
AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,
More informationImmune Checkpoint Blockade in Acute Myeloid Leukemia. Kinsey McCormick Hematology Fellow s Conference January 10, 2014
Immune Checkpoint Blockade in Acute Myeloid Leukemia Kinsey McCormick Hematology Fellow s Conference January 10, 2014 Overview Overview of immune checkpoints Immune checkpoints as mechanism of immune evasion
More informationRheumatoid arthritis: an overview. Christine Pham MD
Rheumatoid arthritis: an overview Christine Pham MD RA prevalence Chronic inflammatory disease affecting approximately 0.5 1% of the general population Prevalence is higher in North America (approaching
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationCancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center
Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Bodnar s Law Simple Things are Important Very Simple Things are Very Important
More informationspecific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins
Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes
More informationPredictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University
Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University Changing Paradigms in Cancer Treatment Potential Uses of Biomarkers Adverse event
More informationThe immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor
The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer
More informationCancer and the immune system: can we beat cancer at its own game?
Cancer and the immune system: can we beat cancer at its own game? Andrew R. Haas, MD, PhD Assistant Professor of Medicine University of Pennsylvania Medical Center Philadelphia, Pa Why can t immune
More informationFigure 14.2 Overview of Innate and Adaptive Immunity
I M M U N I T Y Innate (inborn) Immunity does not distinguish one pathogen from another Figure 14.2 Overview of Innate and Adaptive Immunity Our first line of defense includes physical and chemical barriers
More informationCONTENT. Chapter 1 Review of Literature. List of figures. List of tables
Abstract Abbreviations List of figures CONTENT I-VI VII-VIII IX-XII List of tables XIII Chapter 1 Review of Literature 1. Vaccination against intracellular pathogens 1-34 1.1 Role of different immune responses
More informationOncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March 2015. Antti Vuolanto, COO and co-founder
Oncos Therapeutics: Personalized Cancer Immunotherapy ONCOS THERAPEUTICS Personalized Cancer Immunotherapy March 2015 Antti Vuolanto, COO and co-founder 1 History of Oncos Therapeutics 2002 2007 2009 Research
More informationAsthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System
1 2 3 4 5 6 7 8 9 Asthma (With a little SCID to start) Lauren Smith, MD CHKD Pediatric Allergy/Immunology Disclosures None Will be discussing some medications that are not yet FDA approved Outline SCID
More informationA disease and antibody biology approach to antibody drug discovery
A disease and antibody biology approach to antibody drug discovery Björn Frendéus, PhD VP, Preclinical research Presenter: Björn Frendéus Date: 2011-11-08 1 Antibodies have revolutionized Cancer Treatment!
More informationB Cells and Antibodies
B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production
More informationMedical Therapies Limited EGM Presentation
Medical Therapies Limited EGM Presentation Maria Halasz Chief Executive Officer 5 May 2009 1 Agenda 1. Company information 2. Recent developments 3. Business strategy 4. Key value inflection points for
More informationDrug Development Services
Drug Development Services USING BLOOD AND BONE MARROW PRIMARY CELL SYSTEMS Clinically Relevant In Vitro Assays Broad Spectrum of Drug Classes Multi-Species Platforms Enhancing Drug Development through
More informationNatalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia
Pathogenesis of Dengue Natalia Taborda Vanegas Doc. Sci. Student Immunovirology Group Universidad de Antioquia Infection process Epidermis keratinocytes Dermis Archives of Medical Research 36 (2005) 425
More informationBiologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
More informationMicrobiology AN INTRODUCTION EIGHTH EDITION
TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein
More informationCore Topic 2. The immune system and how vaccines work
Core Topic 2 The immune system and how vaccines work Learning outcome To be able to describe in outline the immune system and how vaccines work in individuals and populations Learning objectives Explain
More informationGive a NOD to diabetes:
Give a NOD to diabetes: NOD proteins ti link immunity it and metabolism tbli Jonathan Schertzer McMaster University McMaster University Faculty of Health Sciences Department of Biochemistry and Biomedical
More informationCytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D.
Cytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D. A shift in medicine is taking place. It is characterized by the emergence of neuroendoimmunology (NEI), a
More informationThe Immunopathogenesis of Relapsing MS
The Immunopathogenesis of Relapsing MS Olaf Stüve, M.D., Ph.D. Neurology Section VA North Texas Health Care System Dallas VA Medical Center Departments of Neurology and Neurotherapeutics University of
More information1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.
Prof. Lester s BIOL 210 Practice Exam 4 (There is no answer key. Please do not email or ask me for answers.) Chapters 15, 16, 17, 19, HIV/AIDS, TB, Quorum Sensing 1) Siderophores are bacterial proteins
More informationGene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press
Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction
More informationThe Immune System and Disease
Chapter 40 The Immune System and Disease Section 40 1 Infectious Disease (pages 1029 1033) This section describes the causes of disease and explains how infectious diseases are transmitted Introduction
More informationMethods for Measuring Dose Escalation in TNF Antagonists for Rheumatoid Arthritis Patients Treated in Routine Clinical Practice
Methods for Measuring Dose Escalation in TNF Antagonists for Rheumatoid Arthritis Patients Treated in Routine Clinical Practice Gu NY 1, Huang XY 2, Globe D 2, Fox KM 3 1 University of Southern California,
More informationDendritic Cells: A Basic Review *last updated May 2003
*last updated May 2003 Prepared by: Eric Wieder, PhD MD Anderson Cancer Center Houston, TX USA What is a dendritic cell? Dendritic cells are antigen-presenting cells (APCs) which play a critical role in
More informationAutoimmunity. Autoimmunity. Genetic Contributions to Autoimmunity. Targets of Autoimmunity
Autoimmunity Factors predisposing an individual to autoimmune disease Mechanisms of initiation of autoimmunity Pathogenesis of particular autoimmune disease Animal models of autoimmune disease Treatment
More informationThe Immune System: A Tutorial
The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The
More informationBIOM 255 - Firestein, Winter 2009. Rheumatoid arthritis. Page 1
Rheumatoid arthritis Page 1 Vascular events in RA Synovium in rheumatoid arthritis Non-extra articular RA Extra articular RA Turesson, et al. Ann Rheum Dis. 2007;66:60 Normal Rheumatoid Arthritis Major
More informationA Local Stability of Mathematical Models for Cancer Treatment by Using Gene Therapy
International Journal of Modeling Optimization, Vol 5, No 3, June 2015 A Local Stability of Mathematical Models for Cancer Treatment by Using Gene Therapy Dwi Lestari Ratnasari Dwi Ambarwati Abstract This
More information10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.
Virus and Immune System Review Directions: Write your answers on a separate piece of paper. 1. Why does a cut in the skin threaten the body s nonspecific defenses against disease? a. If a cut bleeds, disease-fighting
More informationBioMmune Technologies Inc. Corporate Presentation 2015
BioMmune Technologies Inc Corporate Presentation 2015 * Harnessing the body s own immune system to fight cancer & other autoimmune diseases BioMmune Technologies Inc. (IMU) ABOUT A public biopharmaceutical
More informationOverview of the Cattle Immune System 1
Oregon State University BEEF043 Beef Cattle Library Beef Cattle Sciences Overview of the Cattle Immune System 1 Reinaldo F. Cooke 2 Introduction On average, the U.S. cattle industry loses more than $1
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: adoptive_immunotherapy 11/1993 3/2016 3/2017 3/2016 Description of Procedure or Service The spontaneous regression
More informationStem cell treatments of rheumatoid. arthritis and the implications of. their use in treating the condition
Stem cell treatments of rheumatoid arthritis and the implications of their use in treating the condition BY Samuel House Mark Strangwood Grade awarded: Pass with Merit Research paper based on pathology
More informationImmunosuppressive drugs
Immunosuppressive drugs RJM ten Berge Afd. Inw. Geneeskunde AMC contents overview targets mechanism of action Effects on immune capacity measured by responses to vaccination Immune response 1 calcineurin
More informationBVIG/SBMI Meeting 2007. Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium
Dendritic cells : from bench to bedside BVIG/SBMI Meeting 2007 Bart N. Lambrecht, MD, PhD Department of Respiratory Diseases University Hospital Gent, Belgium Outline Role of DCs in the immune system Role
More informationImmunology and immunotherapy in allergic disease
Immunology and immunotherapy in allergic disease Jing Shen, MD Faculty Advisor: Matthew Ryan, MD The University of Texas Medical Branch Department of Otolaryngology Grand Rounds Presentation February 2005
More informationFINAL REPORT For Japan-Korea Joint Research Project AREA
(Form4-2) FINAL REPORT For Japan-Korea Joint Research Project AREA 1. Mathematics & Physics 2. Chemistry & Material Science 3. Biology 4. Informatics & Mechatronics 5. Geo-Science & Space Science 6. Medical
More informationA link between gut microbiota, mucosal immunity and autoimmune arthritis. Hsin-Jung Joyce Wu "Microbiota and man: the story about us
A link between gut microbiota, mucosal immunity and autoimmune arthritis Microbes and Man The majority of microbes we encounter are gut microbiota that live mostly in harmony with their host Duodenum 10
More informationImmune modulation in rheumatology. Geoff McColl University of Melbourne/Australian Rheumatology Association
Immune modulation in rheumatology Geoff McColl University of Melbourne/Australian Rheumatology Association A traditional start to a presentation on biological agents in rheumatic disease is Plasma cell
More informationThe Body s Defenses CHAPTER 24
CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,
More informationOverview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development
Overview B cell development Transcriptional cascades Amazing aspects of lineage plasticity Conventional (B2) B cell development What happens to an autoreactive B cell? B1 vs B2 cells Key anatomical sites
More informationCHAPTER 35 HUMAN IMMUNE SYSTEM STANDARDS:SC.912.L.14.52 & SC.912.L.14.6
CHAPTER 35 HUMAN IMMUNE SYSTEM STANDARDS:SC.912.L.14.52 & SC.912.L.14.6 SECTION 1 - Infectious Disease 1.Identify the causes of infectious disease. 2.Explain how infectious diseases are spread. Causes
More informationMEDICAL BREAKTHROUGHS RESEARCH SUMMARY
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: Training the Body to Fight Melanoma REPORT: 3823 BACKGROUND: Melanoma is the most dangerous form of skin cancer that can be hard to treat and fatal if not
More informationObjectives: Immunity Gone Wrong: Autoimmune Diseases in Dental Hygiene Practice
Objectives: 1) Understand the concept of self- tolerance versus non- self- tolerance. 2) Recognize systemic and oral indicators of autoimmune diseases. 3) Identify various autoimmune diseases and their
More informationClinically Actionable Biomarkers in Rheumatoid Arthritis
Clinically Actionable Biomarkers in Rheumatoid Arthritis PepTalk January 6, 2009 William Robinson, MD, PhD Stanford University School of Medicine VA Palo Alto Health Care System T cell mediated Autoimmune
More informationCytotoxic and Biotherapies Credentialing Programme Module 2
Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal
More informationChapter 18: Applications of Immunology
Chapter 18: Applications of Immunology 1. Vaccinations 2. Monoclonal vs Polyclonal Ab 3. Diagnostic Immunology 1. Vaccinations What is Vaccination? A method of inducing artificial immunity by exposing
More informationHypersensitivity. TYPE I Hypersensitivity Classic allergy. Allergens. Characteristics of allergens. Allergens. Mediated by IgE attached to Mast cells.
Gel and Coombs classification of hypersensitivities. Hypersensitivity Robert Beatty Type I Type II Type III Type IV MCB150 IgE Mediated IgG/IgM Mediated IgG Mediated T cell Classic Allergy rbc lysis Immune
More informationImmuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
More informationCCR Biology - Chapter 9 Practice Test - Summer 2012
Name: Class: Date: CCR Biology - Chapter 9 Practice Test - Summer 2012 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Genetic engineering is possible
More informationImmunotherapy Concept Turned Reality
Authored by: Jennifer Dolan Fox, PhD VirtualScopics Inc. jennifer_fox@virtualscopics.com +1 585 249 6231 Immunotherapy Concept Turned Reality Introduction While using the body s own immune system as a
More informationInternational Symposium on Malignant Mesothelioma 2011 -- curemeso.org
Measles virotherapy for malignant mesothelioma Manish R. Patel, D.O. Assistant Professor of Medicine University of Minnesota June 25, 2011 Medical Treatment of Mesothelioma Majority of patients are not
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Evaluation of Medicines for Human Use London, 10 October 2007 Doc. Ref. COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON POTENCY TESTING OF CELL BASED IMMUNOTHERAPY
More informationWhat You Need to Know About Lung Cancer Immunotherapy
What You Need to Know About Lung Cancer Immunotherapy Lung.org/immunotherapy What is immunotherapy? Immunotherapy for cancer, sometimes called immune-oncology, is a type of medicine that treats cancer
More informationBasic Overview of Preclinical Toxicology Animal Models
Basic Overview of Preclinical Toxicology Animal Models Charles D. Hebert, Ph.D., D.A.B.T. December 5, 2013 Outline Background In Vitro Toxicology In Vivo Toxicology Animal Models What is Toxicology? Background
More informationThe Prospect of Stem Cell Therapy in Multiple Sclerosis. Multiple sclerosis is a multifocal inflammatory disease of the central
The Prospect of Stem Cell Therapy in Multiple Sclerosis Multiple sclerosis is a multifocal inflammatory disease of the central nervous system that generally affects young individuals, causing paralysis
More informationAdditional file 1. Progress of phase II clinical trials of Panagen
Additional file 1. Progress of phase II clinical trials of Panagen Documentation Phase II clinical trial of preparation Panagen was performed in compliance with the following documentation: Approval of
More informationABOUT RHEUMATOID ARTHRITIS
MEDIA BACKGROUNDER ABOUT RHEUMATOID ARTHRITIS Rheumatoid arthritis (RA) is a type of arthritis (chronic inflammatory polyarthritis) that typically affects hands and feet, although any joint in the body
More informationImmunity. Humans have three types of immunity innate, adaptive, and passive: Innate Immunity
Immunity Humans have three types of immunity innate, adaptive, and passive: Innate Immunity Everyone is born with innate (or natural) immunity, a type of general protection. Many of the germs that affect
More informationSingle-celled microorganisms, which can live inside or outside the body. Some cause sickness, but others are harmless.
The Science behind the Noses are Red show: Introduction: The Noses are Red show is about allergies and the biological causes behind them. In order to explain allergies you need to understand a certain
More informationPresenter Disclosure: Renier J. Brentjens, MD, PhD. Nothing to disclose
Presenter Disclosure: Renier J. Brentjens, MD, PhD Nothing to disclose Adoptive Therapy of Cancer with T cells Genetically Targeted to Tumor Associated Antigens through the Introduction of Chimeric Antigen
More informationFocus on CNS Drug Development Treating secondary progressive multiple sclerosis. Simon Wilkinson, CEO
Focus on CNS Drug Development Treating secondary progressive multiple sclerosis Simon Wilkinson, CEO Forward Looking Statements 2 This Presentation (and any financial information that may be provided by
More informationBasics of Immunology
Basics of Immunology 2 Basics of Immunology What is the immune system? Biological mechanism for identifying and destroying pathogens within a larger organism. Pathogens: agents that cause disease Bacteria,
More informationChapter 16: Innate Immunity
Chapter 16: Innate Immunity 1. Overview of Innate Immunity 2. Inflammation & Phagocytosis 3. Antimicrobial Substances 1. Overview of Innate Immunity The Body s Defenses The body has 2 types of defense
More informationThis information can also be found in the Summit 2011 Program on page 8.
If you would like to receive CME credit for this activity, please visit: http://www.pesgce.com/pvasummit2011/ This information can also be found in the Summit 2011 Program on page 8. Newer Treatments:
More informationWhy use passive immunity?
Vaccines Active vs Passive Immunization Active is longer acting and makes memory and effector cells Passive is shorter acting, no memory and no effector cells Both can be obtained through natural processes:
More informationFocus on Preventing Disease. keeping an eye on a healthy bottom line. Cattle Industry
Focus on Preventing Disease keeping an eye on a healthy bottom line Cattle Industry Multimin + VACCINES : University OF FLORIDA study data Study 1 Effect of injectable trace minerals on the humoral immune
More informationHUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13
SECTION 13 HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES CONTACT INFORMATION Jason Cyster, PhD (Email) READING Basic Immunology: Functions and Disorders of the Immune System. Abbas,
More informationWelcome to Mini Med School at the Child & Family Research Institute
Glossary Welcome to Mini Med School at the Child & Family Research Institute On behalf of the Faculty and Staff at the Child & Family Research Institute (CFRI), we would like to welcome you to CFRI s
More informationAn Introduction To Immunotherapy And The Promise Of Tissue Phenomics
An Introduction To Immunotherapy And The Promise Of Tissue Phenomics INSIDE: n The Potential of Immunotherapy n Towards an Understanding of Immunotherapy n Current Approaches to Immunotherapy n The Immunotherapy
More informationIf you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
More informationOne of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:
Immune system. One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types: (pathogen - disease causing organism) 1) Non specific. Anything foreign
More informationRheumatoid Arthritis
Rheumatoid Arthritis Carole Callaghan Principal Pharmacist NHS Lothian Aim To update pharmacists on the current management of rheumatoid arthritis and explore ways to implement pharmaceutical care for
More informationLymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein
WLHS/A&P/Oppelt Name Lymphatic System Practice 1. Figure 12-1 provides an overview of the lymphatic vessels. First color code the following structures. Color code in Figure 12-1 Heart Veins Lymphatic vessels/lymph
More informationMedia Release. Basel, 11 June 2009. RA patients with enhanced response identified
Media Release Basel, 11 June 2009 New data demonstrate the ability of MabThera to reduce the progression of joint damage when used as a first-line biologic treatment in rheumatoid arthritis RA patients
More informationMULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist
MULTIPLE MYELOMA Dr Malkit S Riyat MBChB, FRCPath(UK) Consultant Haematologist Multiple myeloma is an incurable malignancy that arises from postgerminal centre, somatically hypermutated B cells.
More informationRoche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy
Media Release Basel, 6 June 2012 Roche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced
More informationStaph Protein A, Immune Complexes, Cryoglobulins, and the Treatment of Rheumatoid Arthritis:
Staph Protein A, Immune Complexes, Cryoglobulins, and the Treatment of Rheumatoid Arthritis: Immunomodulation, not Immunosuppression Written by Craig Wiesenhutter, M.D. January 2016 This paper has been
More informationGene Silencing Oligos (GSOs) Third Generation Antisense
Gene Silencing Oligos (GSOs) Third Generation Antisense Walter R. Strapps, Ph.D. Executive Director, RNA Therapeutics Idera Pharmaceuticals Cambridge, MA NASDAQ: IDRA www.iderapharma.com Idera is a leader
More informationRecent Multiple Sclerosis (MS)
neuroscience Promoting Remyelination and Preventing Demyelination New Research Goals in Finding a Therapy for Multiple Sclerosis Priya Rajgopal 11 24 Recent Multiple Sclerosis (MS) research has made it
More informationSINPE trial, Ann Surg 2009. Overall morbidity. Minor Major. Infectious Non infectious. Post-hoc analysis WL < %5 (n=379) WL between 5-10% (n=49)
Chinese International Symposium on Nutritional Oncology Changchun, June 20-21 2014 IMMUNONUTRITION IN CANCER PATIENTS IMMUNONUTRITION IN SURGERY OBJECTIVE To get the patient undergoing major surgery for
More informationbiologics for the treatment of psoriasis
How to contact us The Psoriasis Association Dick Coles House 2 Queensbridge Northampton NN4 7BF tel: 08456 760 076 (01604) 251 620 fax: (01604) 251 621 email: mail@psoriasis-association.org.uk www.psoriasis-association.org.uk
More informationVitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model
Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Robyn Balden & Farida Sohrabji Texas A&M Health Science Center- College of Medicine ISC
More informationNEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds
NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds CANCER IMMUNOTHERAPY - Breakthrough of the Year in Science magazine 2013.
More informationVPM 152. INFLAMMATION: Chemical Mediators
General Pathology VPM 152 INFLAMMATION: Chemical Mediators CHEMICAL MEDIATORS OF INFLAMMATION Definition: any messenger that acts on blood vessels, inflammatory cells or other cells to contribute to an
More information1 DNA Vaccines An Overview
1 1 DNA Vaccines An Overview Britta Wahren and Margaret Liu 1.1 Rationale for DNA Vaccines Administration of genes via DNA or RNA may be considered the next-generation of scientific development following
More informationMouse IFN-gamma ELISpot Kit
Page 1 of 8 Mouse IFN-gamma ELISpot Kit Without Plates With Plates With Sterile Plates Quantity Catalog Nos. 862.031.001 862.031.001P 862.031.001S 1 x 96 tests 862.031.005 862.031.005P 862.031.005S 5 x
More informationLymphomas after organ transplantation
Produced 21.03.2011 Revision due 21.03.2011 Lymphomas after organ transplantation People who have undergone an organ transplant are more at risk of developing lymphoma known as post-transplant lymphoproliferative
More informationThe public health risk of influenza in pigs recent insights, key knowledge gaps
The public health risk of influenza in pigs recent insights, key knowledge gaps Prof. Kristien Van Reeth Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Belgium H1N1, H3N2 and
More information